Perhaps, as SYNPO is detectable in plasma exosome and it shows lower level in patients with frontotemporal dementia and AD [45], a similar trend could be obtained in subjects of Lewy body dementias thus making it a potential biomarker candidate. This evidence concerns the gene SYNPO and Lewy body dementia.